Skip to content

SoftBank-Backed Cancer Detection Startup May Go Public as Soon as 2023

  • Japan’s AI Medical Service rides investor interest in med tech
  • AIM plans to launch stomach cancer screening service this year
Tomohiro Tada
Tomohiro TadaSource: AI Medical Service Inc.

SoftBank Group Corp.-backed AI Medical Service Inc., which specializes in endoscopy analysis, is taking steps for a possible initial public offering in Tokyo as early as next year.

The Japanese startup, which develops software to scan endoscopy images and identify potential cancers, has selected a lead manager for the IPO and is in talks with the Tokyo Stock Exchange, founder and Chief Executive Officer Tomohiro Tada said in an interview.